What is TLX's relative strength rating?

TLX ranks at the 78th percentile over 1 month, 84th percentile over 3 months, 92th percentile over 6 months, 42th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is TLX in?

TLX is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is TLX in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). TLX benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

TLX currently shows a 20-day average daily range (ADR%) of 2.0%, a 90-day beta versus the S&P 500 of 0.96. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does TLX have a seasonal pattern?

TickerStance computes TLX's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what TLX has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did TLX last report earnings?

No SEC EDGAR filings are linked to TLX in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Telix Pharmaceuticals Limited American Depositary Shares...

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Telix Pharmaceuticals Limited American Depositary Shares (TLX) has a 3-month relative strength percentile of 84 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.0%, relative volume 2.30×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month84pctile

6 month92pctile

1 year42pctile

Classic78IBD pctile

LDR72leadership

0 of 5 lenses lit · avg RS pctile 74

!ADR%2.0%✓A/DA✓RVOL2.30×!$ Vol$2M

COMPUTED · AS OF 2026-08-24

Pattern read

TLX is in a stage 2 uptrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 6.7% / 24.7%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

3 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

78

3m

84

6m

92

1y

42

LDR

—

StageWeinstein stage analysis

Stage 2 · Uptrend✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · TLX

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
TLX
84RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

DYNDyne Therapeutics, Inc. Common Stock92 SERSerina Therapeutics, Inc.92 INMInMed Pharmaceuticals Inc. Common Shares92 KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares92

§ Seasonality

10y · since 2024

Best monthMar on averageavg +12.61% · 50% win · n 2

Worst monthAug on averageavg -29.73% · 0% win · n 1

TLX monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	TLX Jan avg: 8.99% median: 8.99% win: 50% σ: 16.68% n: 2 2024-11-15 → 2026-07-31	TLX Feb avg: -1.87% median: -1.87% win: 0% σ: 2.07% n: 2 2024-11-15 → 2026-07-31	TLX Mar avg: 12.61% median: 12.61% win: 50% σ: 27.43% n: 2 2024-11-15 → 2026-07-31	TLX Apr avg: 9.38% median: 9.38% win: 100% σ: 7.87% n: 2 2024-11-15 → 2026-07-31	TLX May avg: -8.31% median: -8.31% win: 0% σ: 8.43% n: 2 2024-11-15 → 2026-07-31	TLX Jun avg: 8.43% median: 8.43% win: 50% σ: 19.57% n: 2 2024-11-15 → 2026-07-31	TLX Jul avg: -14.83% median: -14.83% win: 0% σ: 0.85% n: 2 2024-11-15 → 2026-07-31	TLX Aug avg: -29.73% median: -29.73% win: 0% σ: 0.00% n: 1 2024-11-15 → 2026-07-31 (current)	TLX Sep avg: 0.21% median: 0.21% win: 100% σ: 0.00% n: 1 2024-11-15 → 2026-07-31	TLX Oct avg: 11.39% median: 11.39% win: 100% σ: 0.00% n: 1 2024-11-15 → 2026-07-31	TLX Nov avg: 1.10% median: 1.10% win: 50% σ: 10.98% n: 2 2024-11-15 → 2026-07-31	TLX Dec avg: -15.68% median: -15.68% win: 0% σ: 12.80% n: 2 2024-11-15 → 2026-07-31

ETF OWNERS

ETFs holding TLX

TLX appears in 1 ETF as of May 2026: APIE at 0.01% weight, $76K notional.

Held by 1 ETFs · $76K across latest filings · largest weight 0.01% (APIE).

ETFs holding: 1
Total value: $76K
Top 3 concentration: 100.0%
Max weight: APIE · 0.01%

Top 1 by value, from SEC N-PORT-P filings dated May 2026.

ETFs holding TLX ranked by value
ETF	Weight	Value	Δ
APIE	0.01%	$76K	new

APIE new

As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.

Public attention · TLX

Is the crowd watching?

63/ 100 · vs its own 90-day norm▲ 11 vs 7dLate-cycle leader

Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Floatn/a

Shares out338.8Mshares

Market cap$4.0BMid Cap

FAQ

Frequently asked questions

What is TLX's relative strength rating?: TLX ranks at the 78th percentile over 1 month, 84th percentile over 3 months, 92th percentile over 6 months, 42th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is TLX in?: TLX is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is TLX in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). TLX benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is TLX?: TLX currently shows a 20-day average daily range (ADR%) of 2.0%, a 90-day beta versus the S&P 500 of 0.96. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does TLX have a seasonal pattern?: TickerStance computes TLX's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what TLX has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

APPEARS IN

Featured in these lists

1 list

ADR Tight

Telix Pharmaceuticals Limited American Depositary Shares (TLX) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

§ Seasonality

ETFs holding TLX

Is the crowd watching?

Company snapshot

Frequently asked questions

Featured in these lists

How much does it move?

§ Seasonality

Telix Pharmaceuticals Limited American Depositary Shares (TLX) — Stance & relative strength

TLX is on the watchlist, not confirmed. 3m RS is 84, Market Stance is mixed at 47.8, A/D rating A

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding TLX

Is the crowd watching?

Company snapshot

Frequently asked questions

Featured in these lists

How much does it move?